These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 23730873

  • 1. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
    Acquazzino MA, Fischer RT, Langnas A, Coulter DW.
    Pediatr Transplant; 2013 Aug; 17(5):466-71. PubMed ID: 23730873
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature.
    Li M, Goldfinger D, Yuan S.
    Transfusion; 2012 Jan; 52(1):48-54. PubMed ID: 21790626
    [Abstract] [Full Text] [Related]

  • 3. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.
    Int J Cardiol; 2014 Jan 15; 171(1):15-23. PubMed ID: 24309084
    [Abstract] [Full Text] [Related]

  • 4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 5. Cold agglutinin syndrome in pediatric liver transplant recipients.
    Wong W, Merker JD, Nguyen C, Berquist W, Jeng M, Viele M, Glader B, Fontaine MJ.
    Pediatr Transplant; 2007 Dec 15; 11(8):931-6. PubMed ID: 17976131
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.
    Valentini RP, Imam A, Warrier I, Ellis D, Ritchey AK, Ravindranath Y, Shapiro R, Moritz ML.
    Pediatr Transplant; 2006 May 15; 10(3):358-61. PubMed ID: 16677361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. mTOR inhibitor monotherapy. A good treatment choice in renal transplantation?
    Franco-Esteve A, Tordera D, de la Sen ML, Jiménez L, Mas P, Muñoz C, Olivares J.
    Nefrologia; 2012 May 15; 32(5):631-8. PubMed ID: 23013949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients.
    Vallin M, Guillaud O, Morard I, Gagnieu MC, Mentha G, Adham M, Morelon E, Boillot O, Giostra E, Dumortier J.
    Clin Transplant; 2011 May 15; 25(4):660-9. PubMed ID: 21158921
    [Abstract] [Full Text] [Related]

  • 15. Everolimus in clinical practice in long-term liver transplantation: an observational study.
    Casanovas T, Argudo A, Peña-Cala MC.
    Transplant Proc; 2011 May 15; 43(6):2216-9. PubMed ID: 21839237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.